Behavioral Profiling as a Strategy to Stem Weight-Loss Drug Discontinuation

The upcoming Xtalks webinar on October 29, 2026, aims to address this attrition by examining the intersection of biometric data and patient psychology. Experts from Clinical ink—including Christian Djurhuus, MD, PhD, and Nicholas Alp, MD, PhD—will present findings from a study of 1,056 U.S. adults. The research utilizes the SPUR behavioral framework to categorize patients based on treatment identity, confidence, and internal motivations, rather than relying solely on clinical metrics.

By integrating biometrics with sociometrics and psychometrics, the speakers argue that pharma professionals can identify adherence risks before patients abandon their regimens. The session will introduce Kaitality, a wellness platform designed to synthesize these data points into personalized support programs. This approach seeks to move beyond the common hurdles of cost and side effects, focusing instead on the underlying beliefs that dictate long-term engagement with obesity therapies.